Pathak, Gita A.
Singh, Kritika http://orcid.org/0000-0001-9872-7942
Wendt, Frank R. http://orcid.org/0000-0002-2108-6822
Fleming, Tyne W.
Overstreet, Cassie
Koller, Dora http://orcid.org/0000-0002-0415-0466
Tylee, Daniel S. http://orcid.org/0000-0002-7579-6096
De Angelis, Flavio
Cabrera Mendoza, Brenda
Levey, Daniel F. http://orcid.org/0000-0001-8431-9569
Koenen, Karestan C.
Krystal, John H. http://orcid.org/0000-0001-6952-1726
Pietrzak, Robert H.
O’ Donell, Christopher
Gaziano, J. Michael
Falcone, Guido
Stein, Murray B. http://orcid.org/0000-0001-9564-2871
Gelernter, Joel http://orcid.org/0000-0002-4067-1859
Pasaniuc, Bogdan
Mancuso, Nicholas http://orcid.org/0000-0002-9352-5927
Davis, Lea K. http://orcid.org/0000-0001-5143-2282
Polimanti, Renato http://orcid.org/0000-0003-0745-6046
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse
U.S. Department of Health & Human Services | NIH | National Institute on Deafness and Other Communication Disorders
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health
U.S. Department of Health & Human Services | NIH | National Human Genome Research Institute
Article History
Received: 28 October 2021
Revised: 3 February 2022
Accepted: 14 February 2022
First Online: 3 March 2022
Competing interests
: RP and JG are paid for their editorial work on the journal Complex Psychiatry. JHK has served as a scientific consultant (Individual Consultant Agreements less than $5000 per year) to Amgen, AstraZeneca Pharmaceuticals, Bigen, Idec, MA, Biomedisyn Corporation, Forum Pharmaceuticals, Janssen Research & Development, Otsuka America Pharmaceutical, Sunovion Pharmaceuticals, Takeda Industries, and Taisho Pharmaceutical Co; is on the Scientific Advisory Board for Biohaven Pharmaceuticals, Blackthorn Therapeutics, Lohocla Research Corporation, Luc Therapeutics, Pfizer Pharmaceuticals, Tand RImaran Pharma; holds stock in Biohaven Pharmaceuticals Medical Sciences and stock options in Blackthorn Therapeutics and Luc Therapeutics; and is editor of Biological Psychiatry (income greater than $10,000 per year). JG is named as an inventor on PCT patent application no. 15/878,640 entitled “Genotype-guided dosing of opioid agonists,” filed January 24, 2018. RHP is a scientific consultant to Cogstate for work that bears no relationship to the current study. The other authors report no biomedical financial interests or potential conflicts of interest.